...
首页> 外文期刊>Journal of Macromolecular Science, Part A: Pure and Applied Chemistry >Preparation and Characterization of a Novel Drug Delivery System: Biodegradable Nanoparticles in Thermosensitive Chitosan/Gelatin Blend Hydrogels
【24h】

Preparation and Characterization of a Novel Drug Delivery System: Biodegradable Nanoparticles in Thermosensitive Chitosan/Gelatin Blend Hydrogels

机译:新型药物传递系统的制备和表征:壳聚糖/明胶共混水凝胶中的生物可降解纳米颗粒

获取原文
获取原文并翻译 | 示例
           

摘要

A novel injectable in situ gelling drug delivery system (DDS) consisting of biodegradable N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (HTCC) nanoparticles and thermosensitive chitosan/gelatin blend hydrogels was developed for prolonged and sustained controlled drug release. Four different HTCC nanoparticles, prepared based on ionic process of HTCC and oppositely charged molecules such as sodium tripolyphosphate, sodium alginate and carboxymethyl chitosan, were incorporated physically into thermosensitive chitosan/gelatin blend solutions to form the novel DDSs. Resulting DDSs interior morphology was evaluated by scanning electron microscopy. The effect of nanoparticles composition on both the gel process and the gel strength was investigated from which possible hydrogel formation mechanisms were inferred. Finally, bovine serum albumin (BSA), used as a model protein drug, was loaded into four different HTCC nanoparticles to examine and compare the effects of controlled release of these novel DDSs. The results showed that BSA could be sustained and released from these novel DDSs and the release rate was affected by the properties of nanoparticle: the slower BSA release rate was observed from DDS containing nanoparticles with a positive charge than with a negative charge. The described injectable drug delivery systems might have great potential application for local and sustained delivery of protein drugs.View full textDownload full textKeywordsNanoparticles, thermosensitivity, chitosan/gelatin hydrogels, drug delivery systemsRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/10601321003742147
机译:开发了一种新型的可注射原位凝胶给药系统(DDS),该系统由可生物降解的N-(2-羟基)丙基-3-三甲基氯化壳聚糖氯化物(HTCC)纳米粒子和热敏壳聚糖/明胶共混水凝胶组成,用于长期和持续地控制药物释放。将基于HTCC的离子过程制备的四种不同的HTCC纳米颗粒和带相反电荷的分子(如三聚磷酸钠,藻酸钠和羧甲基壳聚糖)物理掺入热敏壳聚糖/明胶共混溶液中,以形成新型DDS。通过扫描电子显微镜评估所得DDS的内部形态。研究了纳米颗粒组成对凝胶过程和凝胶强度的影响,由此推测可能的水凝胶形成机理。最后,将用作模型蛋白药物的牛血清白蛋白(BSA)装入四个不同的HTCC纳米颗粒中,以检查和比较这些新型DDS的控释效果。结果表明,BSA可以从这些新型DDS中持续释放,其释放速率受纳米粒子性能的影响:从含有正电荷的纳米粒子的DDS观察到,比具有负电荷的纳米粒子的BSA释放速率要慢。所描述的注射式药物输送系统可能在蛋白质药物的局部和持续输送中具有巨大的潜在应用。 ::“ citeulike,netvibes,twitter,technorati,美味,linkedin,facebook,stumbleupon,digg,google,更多”,pubid:“ ra-4dff56cd6bb1830b”};添加到候选列表链接永久链接http://dx.doi.org/10.1080/10601321003742147

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号